Cardiology Research Institute, Tomsk National Research Medical Center

Cardiology Research Institute, Tomsk National Research Medical Center

Aim. To assess the prognostic role of cardiac biomarkers (galectin-3, soluble ST2 (sST2), and N-terminal pro-brain natriuretic peptide (NT-proBNP)) in risk stratification of adverse cardiovascular events (CVEs) in patients with heart failure (HF) after implantation of an automatic implantable cardio...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. V. Grakova, K. V. Kopyeva, A. T. Teplyakov, L. K. Isakov, M. N. Sinkova, N. I. Tarasov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2022-08-01
Series:	Российский кардиологический журнал
Subjects:	heart failure adverse cardiovascular events implantable cardioverterdefibrillator biomarkers galectin-3 prognosis
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4753
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prediction of Major Adverse Cardiovascular Events in Patients with Peripheral Artery Disease Using Circulating Immunomodulatory Proteins
by: Ben Li, et al.
Published: (2024-12-01)

Prognosis of cardiovascular events after implantation of a cardioverterdefibrillator in patients with chronic heart failure: the value of increasing concentration of endothelin-1 and soluble forms of ST2 protein in blood plasma
by: A. T. Teplyakov, et al.
Published: (2018-09-01)

Predictive value of circulating galectin-3 in patients with multiple myeloma in remission
by: B. B. Samura
Published: (2015-08-01)

EFFICACY OF CARDIOVERTER-DEFIBRILLATORS IN PREVENTION OF SUDDEN DEATH AND OVERALL MORTALITY DECREASE IN PATIENTS WITH THE SYNDROME OF DILATION CARDIOMYOPATHY: DIFFERENTIAL APPROACH
by: O. V. Blagova, et al.
Published: (2018-03-01)

Clinical use of the new biomarker ST2 in patients with chronic heart failure of ischemic genesis: an exercise test
by: E. V. Grakova, et al.
Published: (2019-09-01)

Cardiology Research Institute, Tomsk National Research Medical Center
by: B. A. Tatarsky, et al.
Published: (2020-08-01)

Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocardial revascularization
by: E. V. Grakova, et al.
Published: (2018-10-01)

Interactions between galectin-3 and cardiovascular risk in patients with chronic lymphocytic leukemia in remission: results of 3-year prospective study
by: B. B. Samura
Published: (2018-10-01)

Increased serum galectin-3 level is associated with endothelial dysfunction and cardiovascular events in patients with hypertension
by: Hui-Sheng Wang, et al.
Published: (2025-01-01)

Predictors of Major Adverse Cardiovascular Events in Stable Patients After ST Elevation Myocardial Infarction
by: Lidija Savic, et al.
Published: (2025-05-01)

Reducing fluoroscopy time during cardioverter-defibrillator implantation, performed with considering of myocardium perfusion scintigraphy results in patients with coronary artery disease
by: T. A. Atabekov, et al.
Published: (2018-12-01)

Contribution of cardio-ankle vascular index to prediction of cardiovascular events in the adult urban population: data from the ESSE-RF study (Tomsk)
by: A. R. Zairova, et al.
Published: (2021-09-01)

Galectin-3 in the blood serum of patients with bone tumors
by: N. E. Kushlinskii, et al.
Published: (2023-07-01)

Diabetes is associated with a poor prognosis in patients with psoriasis and coronary artery disease
by: Lin Zhao, et al.
Published: (2025-07-01)

Prognostic Value of the Tricuspid Regurgitation Impact on Outcomes (TRIO) Score in Patients Undergoing Transcatheter Aortic Valve Implantation
by: Jizhong Wang, et al.
Published: (2025-01-01)

Value of circulating galectin-3 for prognosis of cardiovascular events in patients with chronic lymphocytic leukemia in remission
by: B. B. Samura, et al.
Published: (2014-12-01)

Galectins, antibodies to them and galectin-3 binding protein in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2025-03-01)

Galectin-1 in Cardiovascular Pathogenesis: Unraveling Dual Roles and Mechanistic Insights in Emerging Research
by: Po-Yuan Chen, et al.
Published: (2025-05-01)

Galectins: a potential pharmacological target
by: V. A. Serebryakova, et al.
Published: (2024-10-01)

Cardiovascular toxicity of tisagenlecleucel in children and adolescents: analysis of spontaneous reports submitted to FAERS
by: Ganggang Wang, et al.
Published: (2025-01-01)

Bioinformatics analysis of JUP in patients with acute myocardial infarction and its potential application in clinical prognostic evaluation
by: Xinyue Deng, et al.
Published: (2025-05-01)

Growth Differentiation Factor 15 Predicts Cardiovascular Events in Peripheral Artery Disease
by: Ben Li, et al.
Published: (2025-07-01)

Construction of a predictive model for depressive symptoms following acute myocardial infarction and its impact on prognosis
by: Lei Ren, et al.
Published: (2025-04-01)

Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk
by: V. V. Genkel, et al.
Published: (2021-03-01)

Research progress of galectins in glioma
by: Xin-Li Feng, et al.
Published: (2025-06-01)

Clusters of patients with non-ST-segment elevation acute coronary syndrome depending on the laboratory data
by: D. N. Nedbaeva, et al.
Published: (2024-08-01)

Comparative analysis of galectin-1, galectin-3, and galectin-8 signatures in normal and choriocarcinoma trophoblast cell lines
by: Jovanović Krivokuća Milica, et al.
Published: (2024-01-01)

Galectin-1 and Galectin-3 expression in colon cancer and its correlation with tumor invasion, differentiation, and metastatic spread
by: Yu. V. Kolobovnikova, et al.
Published: (2021-12-01)

Risk factors of adverse cardiovascular prognosis in patients with peripheral artery disease
by: A. R. Askarov, et al.
Published: (2012-12-01)

Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
by: Kristine M. Erlandson, MD, MS, et al.
Published: (2025-09-01)

Eosinophil counts predict 3-year risk of major adverse cardiovascular and cerebrovascular events in carotid artery stenosis patients
by: Ruijing Zhang, et al.
Published: (2025-07-01)

Association between the atherogenic index of plasma and major adverse cardiovascular events in patients with premature coronary artery disease
by: Xiangzhen Ran, et al.
Published: (2025-06-01)

Atherogenic index of plasma and the clinical outcome of patients with acute coronary syndrome: a meta-analysis
by: Sihai Jiang, et al.
Published: (2025-12-01)

Association between triglyceride glucose index and adverse cardiovascular prognosis in patients with atrial fibrillation without diabetes: a retrospective cohort study
by: Aobo Gong, et al.
Published: (2025-01-01)

Urinary metabolomics reveals myo-inositol and (E)-Monocrotophos associate with prognosis in ACS comorbid with T2DM and preserved renal function
by: Mingyu Duan, et al.
Published: (2025-04-01)

A nomogram risk prediction model for ischemic mitral regurgitation after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
by: Jiangping Ye, et al.
Published: (2025-05-01)

Clinical researchs and advances of risk factors for major cardiovascular adverse events in patients with chronic kidney diseases
by: Li Jin-long, et al.
Published: (2022-11-01)

Mortality and cardiorenal outcomes among heart failure patients with zinc deficiency: a multicenter retrospective cohort study of 8,290 patients
by: Yu-Min Lin, et al.
Published: (2025-04-01)

Beta-adrenoblockers in cardiology practice
by: A. A. Garganeeva
Published: (2010-10-01)

Cancer Research Institute, Tomsk National Research Medical Center of the RAS
by: E. L. Choynzonov, et al.
Published: (2019-07-01)